ArticleFrontiers in digital health2025
Parental perceptions of a wearable vital signs monitor for observation of newborns: in-depth interviews in three tertiary hospitals, Southwest Nigeria.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The first 28 days of a newborn's life are a critical time for their survival and subsequent growth and development. Wearable devices have emerged as a potential solution for clinical monitoring, offering affordability, accessibility, and improved patient care. This study explored the acceptability, satisfaction, and perceived benefits of the neoGuard wearable vital signs monitoring device among parents/guardians of sick newborns in Nigeria. Methods: This was a qualitative study conducted between April and December 2022 at three tertiary level health facilities in Nigeria. In-depth interviews were conducted with 17 parents/guardians whose newborns were monitored using the neoGuard technology. Participants were selected based on specific criteria, including observation of at least 2 h of use of the neoGuard technology on their newborn, and interviews were conducted in the participants' preferred language. Interviews were moderated with a semi-structured interview guide and audio recorded. Data were transcribed, coded and analyzed thematically using NVivo software. Results: The majority of participants expressed positive reactions to the neoGuard device, although some initial concerns were reported. Participants appreciated the device's functionality, ease of use, and potential to detect health issues in newborns. The device did not interfere with routine care activities such as cleaning, breastfeeding, or kangaroo care. Participants expressed high levels of confidence in the device's safety and expressed satisfaction with its performance. They suggested improvements such as designing the device to be worn on the wrist instead of the forehead. Conclusion: Overall, the neoGuard wearable vital signs monitor was well accepted by parents/guardians of sick newborns in Nigeria. The device's functionality, ease of use and potential to improve newborn health were positively perceived. Some suggestions for design improvements were provided. These findings highlight the importance of considering the perspectives of parents/guardians, alongside clinicians and other stakeholders, when implementing new technologies in clinical care. Further research should examine the device's clinical impact and cost-effectiveness while considering the experiences and perceptions of both healthcare providers and patients' guardians to inform adoption into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.